Tobias Breidthardt
Experienced in Relapsing Fever

Tobias Breidthardt

Basel, BS, CH 
Experienced in Relapsing Fever
Basel, BS, CH 
OverviewLocationsClinical Research

Overview

Tobias Breidthardt practices in Basel, Switzerland. Mr. Breidthardt is rated as an Experienced expert by MediFind in the treatment of Relapsing Fever. His top areas of expertise are Heart Failure, Pneumonia, Chronic Kidney Disease, and Hyperventilation.

His clinical research consists of co-authoring 91 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Relapsing Fever.

Gender
Male

Locations

Basel, BS, Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Risk Assessment by Cardiovascular Biomarkers in Chronic Dialysis Patients
Risk Assessment by Cardiovascular Biomarkers in Chronic Dialysis Patients
Enrollment Status: Completed
Publish Date: May 12, 2020
Goal-Directed Afterload Reduction in Acute Congestive Cardiac Decompensation Study (GALACTIC)
Goal-Directed Afterload Reduction in Acute Congestive Cardiac Decompensation Study (GALACTIC)
Enrollment Status: Completed
Publish Date: November 21, 2019
Intervention Type: Drug
Study Phase: Phase 4
Recombinant Human C1 Esterase Inhibitor (Conestat Alfa) in the Prevention of Contrast-induced Nephropathy in High-risk Subjects (PROTECT): a Randomized, Placebo-controlled, Double-blind Single-center Trial
Recombinant Human C1 Esterase Inhibitor (Conestat Alfa) in the Prevention of Contrast-induced Nephropathy in High-risk Subjects (PROTECT): a Randomized, Placebo-controlled, Double-blind Single-center Trial
Enrollment Status: Completed
Publish Date: August 08, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

91 Total Publications

A Novel N-Terminal Pro-B-Type Natriuretic Peptide Assay in the Early Diagnosis of Acute Heart Failure.
A Novel N-Terminal Pro-B-Type Natriuretic Peptide Assay in the Early Diagnosis of Acute Heart Failure.
Journal: JACC. Advances
Published: August 18, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Breidthardt's expertise for a condition
ConditionClose
    View All 15 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile